Your search returned 6 results.

Results
	1.	Is there sufficient evidence to consider the use of 11β-hydroxysteroid dehydrogenase type 1 inhibition in children? [electronic resource] by Fürst-Recktenwald, Sabine Dörr, Helmuth G Quinkler, Marcus Dötsch, Jörg Stewart, Paul M Producer: 20121113 In: Clinical endocrinology vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases. [electronic resource] by Piana, Chiara Surh, Linda Furst-Recktenwald, Sabine Iolascon, Achille Jacqz-Aigrain, Evelyne M Jonker, Ineke Russo, Roberta van Schaik, Ron H N Wessels, Judith Della Pasqua, Oscar E Producer: 20120821 In: Journal of clinical pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab. [electronic resource] by Müller, Hermann L Merks, Johannes H M Geoerger, Birgit Grill, Jacques Hargrave, Darren Glade Bender, Julia Gururangan, Sridharan Navid, Fariba Johnston, Michael Bachir, Jeanette Elze, Markus C Fürst-Recktenwald, Sabine Producer: 20191106 In: Pediatric blood & cancer vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration. [electronic resource] by Chakravarthy, Usha Bailey, Clare Brown, David Campochiaro, Peter Chittum, Mark Csaky, Karl Tufail, Adnan Yates, Paul Cech, Patrick Giraudon, Mylene Delmar, Paul Szczesny, Piotr Sahni, Jayashree Boulay, Anne Nagel, Sandra Fürst-Recktenwald, Sabine Schwab, Dietmar Publication details: Ophthalmology. Retina In: Ophthalmology. Retina vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. [electronic resource] by Stefan, Norbert Ramsauer, Markus Jordan, Paul Nowotny, Bettina Kantartzis, Konstantinos Machann, Jürgen Hwang, Jong-Hee Nowotny, Peter Kahl, Sabine Harreiter, Jürgen Hornemann, Silke Sanyal, Arun J Stewart, Paul M Pfeiffer, Andreas F Kautzky-Willer, Alexandra Roden, Michael Häring, Hans-Ulrich Fürst-Recktenwald, Sabine Producer: 20141218 In: The lancet. Diabetes & endocrinology vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study). [electronic resource] by Chisholm, Julia C Merks, Johannes H M Casanova, Michela Bisogno, Gianni Orbach, Daniel Gentet, Jean-Claude Thomassin-Defachelles, Anne-Sophie Chastagner, Pascal Lowis, Stephen Ronghe, Milind McHugh, Kieran van Rijn, Rick R Hilton, Magalie Bachir, Jeanette Fürst-Recktenwald, Sabine Geoerger, Birgit Oberlin, Odile Producer: 20170911 In: European journal of cancer (Oxford, England : 1990) vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)